ArticleCanadian journal of public health = Revue canadienne de sante publique2026
The geographic distribution and community correlates of electronic cigarette use in Canada.
Article in Canadian journal of public health = Revue canadienne de sante publique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectivesElectronic cigarettes and other novel electronic nicotine delivery systems (ENDS) have grown rapidly in popularity and accessibility. In this study, we compiled a large sub-provincial dataset on smoking and vaping behaviour in Canada to inform targeted surveillance and prevention.
methodsTwelve national-level survey datasets were concatenated. Multilevel models were used to derive precision-weighted estimates of census division-level smoking and ENDS use prevalence, adjusted for age, sex/gender, and data source. We developed visualizations of the geography of smoking and ENDS use across Canada and used Census Divisions for spatially explicit correlational analyses of community characteristics associated with vaping.
resultsThe age- and sex-adjusted prevalence of past-month (i.e., current) ENDS use in Canada was 4%, with higher estimates observed in several Atlantic provinces: New Brunswick (5.6%), Prince Edward Island (4.8%), Nova Scotia (4.7%), and Newfoundland and Labrador (4.5%) followed by Manitoba (4.1%). Estimates for the remaining provinces were below 4%. The prevalence of ENDS use varied considerably across CDs, even in provinces where vaping was generally uncommon. Suburban and exurban communities in Ontario and Quebec demonstrated especially high ENDS use. Spatial analyses revealed select correlations with community factors such as economic composition.
conclusionSub-provincial data revealed geographical variability in ENDS use across Canada. Localized surveillance and prevention efforts may be improved by considering the community features associated with high rates of use, and benchmarking regional regulations on the advertising and sales of ENDS products to communities with lower estimated rates of use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.